Mutual interference of HIV and natural killer cell-mediated immune response

Molecular Immunology

Volumn 42, Issue 2, 2005, Pages 239-249

  Jacobs, Roland ^a   Heiken, Hans ^a   Schmidt, Reinhold E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

HIV; MHC I; NK cell

Indexed keywords

ADRENERGIC RECEPTOR; CHEMOKINE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OPIATE RECEPTOR;

ANTIBODY RESPONSE; APOPTOSIS; CYTOKINE PRODUCTION; DOWN REGULATION; HEMATOPOIESIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA;

EID: 5444258175     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.06.021     Document Type: Short Survey

References (128)

1. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 96:2000;3086-3093
2. Anderson P., Caligiuri M., O'Brien C., Manley T., Ritz J., Schlossman S.F. Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc. Natl. Acad. Sci. USA. 87:1990;2274-2278
3. Andre P., Biassoni R., Colonna M., Cosman D., Lanier L.L., Long E.O., Lopez-Botet M., Moretta A., Moretta L., Parham P., Trowsdale J., Vivier E., Wagtmann N., Wilson M.J. New nomenclature for MHC receptors. Nat. Immunol. 2:2001;661
4. Anegon I., Cuturi M.C., Trinchieri G., Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167:1988;452-472
5. Azzoni L., Papasavvas E., Chehimi J., Kostman J.R., Mounzer K., Ondercin J., Perussia B., Montaner L.J. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. J. Immunol. 168:2002;5764-5770
6. Basu S., Sodhi A. Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565. Immunol. Cell Biol. 70(Pt 1):1992;15-24
7. Baume D.M., Robertson M.J., Levine H., Manley T.J., Schow P.W., Ritz J. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur. J. Immunol. 22:1992;1-6
8. Benschop R.J., Jacobs R., Sommer B., Schurmeyer T.H., Raab J.R., Schmidt R.E., Schedlowski M. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB. J. 10:1996;517-524
9. Billadeau D.D., Upshaw J.L., Schoon R.A., Dick C.J., Leibson P.J. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4:2003;557-564
10. Bonaparte M.I., Barker E. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS. 17:2003;487-494
11. Born T.L., Morrison L.A., Esteban D.J., VandenBos T., Thebeau L.G., Chen N., Spriggs M.K., Sims J.E., Buller R.M. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 164:2000;3246-3254
12. Borrego F., Kabat J., Kim D.K., Lieto L., Maasho K., Pena J., Solana R., Coligan J.E. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol. Immunol. 38:2002;637-660
13. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., Landi E., Biassoni R., Notarangelo L.D., Moretta L., Moretta A. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:2001;235-246
14. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature. 405:2000;537-543
15. Brumbaugh K.M., Binstadt B.A., Billadeau D.D., Schoon R.A., Dick C.J., Ten R.M., Leibson P.J. Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J. Exp. Med. 186:1997;1965-1974
16. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4:1996;77-85
17. Burshtyn D.N., Yang W., Yi T., Long E.O. A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J. Biol. Chem. 272:1997;13066-13072
18. Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 171:1990;1509-1526
19. Campbell K.S., Dessing M., Lopez-Botet M., Cella M., Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184:1996;93-100
20. Cantoni C., Ponassi M., Biassoni R., Conte R., Spallarossa A., Moretta A., Moretta L., Bolognesi M., Bordo D. The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure (Cambridge). 11:2003;725-734
21. Carson W.E., Fehniger T.A., Caligiuri M.A. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur. J. Immunol. 27:1997;354-360
22. Chiorean E.G., Miller J.S. The biology of natural killer cells and implications for therapy of human disease. J. Hematother. Stem Cell Res. 10:2001;451-463
23. Chuang L.F., Chuang T.K., Killam K.F. Jr., Chuang A.J., Kung H.F., Yu L., Chuang R.Y. Delta opioid receptor gene expression in lymphocytes. Biochem. Biophys. Res. Commun. 202:1994;1291-1299
24. Chuang L.F., Chuang T.K., Killam K.F. Jr., Qiu Q., Wang X.R., Lin J.J., Kung H.F., Sheng W., Chao C., Yu L., et al. Expression of kappa opioid receptors in human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 209:1995;1003-1010
25. Coscoy L., Ganem D. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107:2001;1599-1606
26. Cretney E., Takeda K., Yagita H., Glaccum M., Peschon J.J., Smyth M.J. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168:2002;1356-1361
27. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., Mosca M., Filliponi F., Brunetto R.M., Bonino F., Abrignani S., Valiante N.M. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195:2002;35-41
28. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., Moretta A., Moretta L. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33:2003;2410-2418
29. Deniz G., Akdis M., Aktas E., Blaser K., Akdis C.A. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur. J. Immunol. 32:2003;884
30. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514
31. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276:1996;626-636
32. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277:1996b;633-645
33. Fecho K., Nelson C.J., Lysle D.T. Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment. Immunopharmacology. 46:2000;193-207
34. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., Caligiuri M.A. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 101:2003;3052-3057
35. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162:1999;4511-4520
36. Ferlazzo G., Morandi B., D'Agostino A., Meazza R., Melioli G., Moretta A., Moretta L. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33:2003;306-313
37. Forthal D.N., Landucci G., Daar E.S. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J. Virol. 75:2001a;6953-6961
38. Forthal D.N., Landucci G., Keenan B. Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count. AIDS Res. Hum. Retroviruses. 17:2001b;553-561
39. Foster C.E., Colonna M., Sun P.D. Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors. J. Biol. Chem. 278:2003;46081-46086
40. Frey M., Packianathan N.B., Fehniger T.A., Ross M.E., Wang W.C., Stewart C.C., Caligiuri M.A., Evans S.S. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 161:1998;400-408
41. Gottschalk L.R., Bray R.A., Kaizer H., Gebel H.M. Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients. Bone Marrow Transplant. 5:1990;259-264
42. Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H.G., Smyth M.J., Chambers B.J. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172:2004;123-129
43. Hercend T., Schmidt R.E. Characteristics and uses of natural killer cells. Immunol. Today. 9:1988;291-293
44. Ishido S., Choi J.K., Lee B.S., Wang C., DeMaria M., Johnson R.P., Cohen G.B., Jung J.U. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity. 13:2000;365-374
45. dim NK cells. Eur. J. Immunol. 31:2001;3121-3126
46. Jacobs R., Karst M., Scheinichen D., Bevilacqua C., Schneider U., Heine J., Schedlowski M., Schmidt R.E. Effects of fentanyl on cellular immune functions in man. Int. J. Immunopharmacol. 21:1999;445-454
47. Jacobs R., Stoll M., Stratmann G., Leo R., Link H., Schmidt R.E. CD16- CD56+ natural killer cells after bone marrow transplantation. Blood. 79:1992;3239-3244
48. Jacobs R., Weber K., Wendt K., Heiken H., Schmidt R.E. Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients. J. Clin. Immunol. 24:2004;281-286
49. Jan C.N., Sutherland C.L., Lawrence W.A., Rein-Weston A., Cosman D. ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 305:2003;129-135
50. Jetschmann J.U., Benschop R.J., Jacobs R., Kemper A., Oberbeck R., Schmidt R.E., Schedlowski M. Expression and in-vivo modulation of alpha- and beta-adrenoceptors on human natural killer (CD16+) cells. J. Neuroimmunol. 74:1997;159-164
51. Johnson H.M., Torres B.A. Complementary peptides as probes to explore neuropeptide receptors on lymphocytes. Immunomethods. 5:1994;167-171
52. Kamp W., Berk M.B., Visser C.J., Nottet H.S. Mechanisms of HIV-1 to escape from the host immune surveillance. Eur. J. Clin. Invest. 30:2000;740-746
53. Karre K., Welsh R.M. Viral decoy vetoes killer cell. Nature. 386:1997;446-447
54. Kasaian M.T., Whitters M.J., Carter L.L., Lowe L.D., Jussif J.M., Deng B., Johnson K.A., Witek J.S., Senices M., Konz R.F., Wurster A.L., Donaldson D.D., Collins M., Young D.A., Grusby M.J. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity. 16:2002;559-569
55. Kim H.R., Park H.J., Park J.H., Kim S.J., Kim K., Kim J. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B. Cancer Immunol. Immunother. 53:2004;461-470
56. Klonz A., Wonigeit K., Pabst R., Westermann J. The marginal blood pool of the rat contains not only granulocytes, but also lymphocytes, NK-cells and monocytes: a second intravascular compartment, its cellular composition, adhesion molecule expression and interaction with the peripheral blood pool. Scand. J. Immunol. 44:1996;461-469
57. Kottilil S., Chun T.W., Moir S., Liu S., McLaughlin M., Hallahan C.W., Maldarelli F., Corey L., Fauci A.S. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis. 187:2003;1038-1045
58. Kurago Z.B., Lutz C.T., Smith K.D., Colonna M. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. J. Immunol. 160:1998;1573-1580
59. Lanier L.L. NK cell receptors. Annu. Rev. Immunol. 16:1998;359-393
60. Lanier L.L., Testi R., Bindl J., Phillips J.H. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169:1989;2233-2238
61. Lanier L.L., Yu G., Phillips J.H. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 342:1989;803-805
62. Leibson P.J. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity. 6:1997;655-661
63. Levitt L.J., Angler A., Lee F., Abrams J., Shatsky M., Thompson D. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor. J. Clin. Invest. 88:1991;67-75
64. Ljunggren H.G., Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today. 11:1990;237-244
65. Long E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:1999;875-904
66. Long E.O., Wagtmann N. Natural killer cell receptors. Curr. Opin. Immunol. 9:1997;344-350
67. Lou Z., Jevremovic D., Billadeau D.D., Leibson P.J. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J. Exp. Med. 191:2000;347-354
68. MacDermott R.P., Schmidt R.E., Caulfield J.P., Hein A., Bartley G.T., Ritz J., Schlossman S.F., Austen K.F., Stevens R.L. Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J. Exp. Med. 162:1985a;1771-1787
69. MacDermott R.P., Schmidt R.E., Caulfield J.P., Hein A., Bartley G.T., Ritz J., Schlossman S.F., Austen K.F., Stevens R.L. Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J. Exp. Med. 162:1985b;1771-1787
70. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 409:2001;1055-1060
71. Marcenaro E., Augugliaro R., Falco M., Castriconi R., Parolini S., Sivori S., Romeo E., Millo R., Moretta L., Bottino C., Moretta A. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity. Eur. J. Immunol. 33:2003;3367-3376
72. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O'Brien S.J., Carrington M. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:2002;429-434
73. Matera L., Contarini M., Bellone G., Forno B., Biglino A. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunology. 98:1999;386-392
74. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA. 100:2003;15011-15016
75. McVicar D.W., Burshtyn D.N., 2001. Intracellular signaling by the killer immunoglobulin-like receptors and LySci.STKE, RE1.
76. Mendila M., Heiken H., Becker S., Stoll M., Kemper A., Jacobs R., Schmidt R.E. Immunologic and virologic studies in long-term nonprogressors with HIV-1 infection. Eur. J. Med. Res. 4:1999;417-424
77. Mingari M.C., Vitale C., Cantoni C., Bellomo R., Ponte M., Schiavetti F., Bertone S., Moretta A., Moretta L. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27:1997;1374-1380
78. Mitsuyasu, R.T., 2001. The potential role of interleukin-2 in HIV. AIDS 15 (Suppl. 2:S22-7), S22-S27.
79. Moretta A., Poggi A., Pende D., Tripodi G., Orengo A.M., Pella N., Augugliaro R., Bottino C., Ciccone E., Moretta L. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J. Exp. Med. 174:1991;1393-1398
80. Moretta L., Biassoni R., Bottino C., Mingari M.C., Moretta A. Human NK-cell receptors. Immunol. Today. 21:2000;420-422
81. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., Johnston J., Madden K., Xu W., West J., Schrader S., Burkhead S., Heipel M., Brandt C., Kuijper J.L., Kramer J., Conklin D., Presnell S.R., Berry J., Shiota F., Bort S., Hambly K., Mudri S., Clegg C., Moore M., Grant F.J., Lofton-Day C., Gilbert T., Rayond F., Ching A., Yao L., Smith D., Webster P., Whitmore T., Maurer M., Kaushansky K., Holly R.D., Foster D. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 408:2000;57-63
82. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L., Moretta A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190:1999;1505-1516
83. Peritt D., Robertson S., Gri G., Showe L., Aste-Amezaga M., Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J. Immunol. 161:1998;5821-5824
84. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517
85. Ritz J., Schmidt R.E., Michon J., Hercend T., Schlossman S.F. Characterization of functional surface structures on human natural killer cells. Adv. Immunol. 42:1988;181-211
86. Robertson M.J. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71:2002;173-183
87. Rolle A., Mousavi-Jazi M., Eriksson M., Odeberg J., Soderberg-Naucler C., Cosman D., Karre K., Cerboni C. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J. Immunol. 171:2003;902-908
88. Saito S., Kasahara T., Sakakura S., Enomoto M., Umekage H., Harada N., Morii T., Nishikawa K., Narita N., Ichijo M. Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Biochem. Biophys. Res. Commun. 200:1994;378-383
89. Schedlowski M., Falk A., Rohne A., Wagner T.O., Jacobs R., Tewes U., Schmidt R.E. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J. Clin. Immunol. 13:1993;344-351
90. Schedlowski M., Hosch W., Oberbeck R., Benschop R.J., Jacobs R., Raab H.R., Schmidt R.E. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J. Immunol. 156:1996;93-99
91. Schedlowski M., Jacobs R., Stratmann G., Richter S., Hadicke A., Tewes U., Wagner T.O., Schmidt R.E. Changes of natural killer cells during acute psychological stress. J. Clin. Immunol. 13:1993;119-126
92. Scheppler J.A., Nicholson J.K., Swan D.C., Ahmed-Ansari A., McDougal J.S. Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. J. Immunol. 143:1989;2858-2866
93. Schmidt R.E., Bartley G., Levine H., Schlossman S.F., Ritz J. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J. Immunol. 135:1985;1020-1025
94. Schmidt R.E., Hercend T., Fox D.A., Bensussan A., Bartley G., Daley J.F., Schlossman S.F., Reinherz E.L., Ritz J. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J. Immunol. 135:1985;672-678
95. Schmidt R.E., MacDermott R.P., Bartley G., Bertovich M., Amato D.A., Austen K.F., Schlossman S.F., Stevens R.L., Ritz J. Specific release of proteoglycans from human natural killer cells during target lysis. Nature. 318:1985;289-291
96. Schmidt R.E., Murray C., Daley J.F., Schlossman S.F., Ritz J. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J. Exp. Med. 164:1986;351-356
97. Sconocchia G., Titus J.A., Segal D.M. Signaling pathways regulating CD44-dependent cytolysis in natural killer cells. Blood. 90:1997;716-725
98. Scott-Algara D., Truong L.X., Versmisse P., David A., Luong T.T., Nguyen N.V., Theodorou I., Barre-Sinoussi F., Pancino G. Increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 171:2003;5663-5667
99. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., Allan D.S., Makadzange A., Rowland-Jones S., Willcox B., Jones E.Y., van der Merwe P.A., Kumagai I., Maenaka K. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA. 100:2003;8856-8861
100. Siliciano R.F., Pratt J.C., Schmidt R.E., Ritz J., Reinherz E.L. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 317:1985;428-430
101. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C., Moretta L., Moretta A. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30:2000;787-793
102. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., Moretta L., Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29:1999;1656-1666
103. Stahls A., Heiskala M., Mustelin T., Andersson L.C. Activation of natural killer cells via the Fc gamma RIII (CD16) requires initial tyrosine phosphorylation. Eur. J. Immunol. 22:1992;611-614
104. Stahls A., Liwszyc G.E., Couture C., Mustelin T., Andersson L.C. Triggering of human natural killer cells through CD16 induces tyrosine phosphorylation of the p72syk kinase. Eur. J. Immunol. 24:1994;2491-2496
105. Stinchcombe J.C., Bossi G., Booth S., Griffiths G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity. 15:2001;751-761
106. Takeda K., Smyth M.J., Cretney E., Hayakawa Y., Kayagaki N., Yagita H., Okumura K. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195:2002;161-169
107. Tarazona R., Casado J.G., Delarosa O., Torre-Cisneros J., Villanueva J.L., Sanchez B., Galiani M.D., Gonzalez R., Solana R., Pena J. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J. Clin. Immunol. 22:2002;176-183
108. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376
109. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:2003;133-146
110. Tseng C.T., Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195:2002;43-49
111. Uhrberg M., Valiante N.M., Young N.T., Lanier L.L., Phillips J.H., Parham P. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J. Immunol. 166:2001;3923-3932
112. Valentin A., Pavlakis G.N. Natural killer cells are persistently infected and resistant to direct killing by HIV-1. Anticancer Res. 23:2003;2071-2075
113. Vales-Gomez M., Reyburn H.T., Erskine R.A., Strominger J. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl. Acad. Sci. USA. 95:1998;14326-14331
114. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 7:1997;739-751
115. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:1998;2065-2072
116. Vitale M., Falco M., Castriconi R., Parolini S., Zambello R., Semenzato G., Biassoni R., Bottino C., Moretta L., Moretta A. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31:2001;233-242
117. Vivier E., Morin P., O'Brien C., Druker B., Schlossman S.F., Anderson P. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J. Immunol. 146:1991;206-210
118. Vujanovic N.L., Nagashima S., Herberman R.B., Whiteside T.L. Nonsecretory apoptotic killing by human NK cells. J. Immunol. 157:1996;1117-1126
119. Wallin R.P., Screpanti V., Michaelsson J., Grandien A., Ljunggren H.G. Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur. J. Immunol. 33:2003;2727-2735
120. Warren H.S., Kinnear B.F., Phillips J.H., Lanier L.L. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J. Immunol. 154:1995;5144-5152
121. Watzl C., Long E.O. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197:2003;77-85
122. Watzl C., Stebbins C.C., Long E.O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165:2000;3545-3548
123. Weber K., Meyer D., Grosse V., Stoll M., Schmidt R.E., Heiken H. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy. Immunobiology. 202:2000;172-178
124. Westermann J., Pabst R. Distribution of lymphocyte subsets and natural killer cells in the human body. Clin. Invest. 70:1992;539-544
125. Wu J., Cherwinski H., Spies T., Phillips J.H., Lanier L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192:2000;1059-1068
126. Young J.D., Cohn Z.A. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. Adv. Immunol. 41:1987;269-332
127. Young J.D., Leong L.G., Liu C.C., Damiano A., Wall D.A., Cohn Z.A. Isolation and characterization of a serine esterase from cytolytic T cell granules. Cell. 47:1986;183-194
128. Young J.D., Liu C.C., Leong L.G., Cohn Z.A. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains. J. Exp. Med. 164:1986;2077-2082